Safety and Efficacy of a Phased Transition From Epogen to Three Times Weekly Oral Vadadustat for the Treatment of Anemia in Subjects Receiving In-Center Hemodialysis

Clinical trial NCT07565701 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07565701
Sponsor: Geoff Block
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia Associated With Chronic Kidney Disease

Start date: 2026-04-01
Primary completion: 2027-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.